New Strategic Partnership with the University of Missouri Research Reactor Center (MURR)

ABK Biomedical Inc. (ABK) is pleased to announce a new multi-year strategic partnership with the University of Missouri Research Reactor Center (MURR®).  MURR is the pre-eminent global leader in research reactors, with extensive experience supplying medical isotopes and irradiation services for medical devices.  MURR is a key partner for ABK to establish seamless manufacturing, supply, and distribution to critical cancer centers globally. MURR will be the primary irradiation partner for ABK’s radio-embolization products currently under development.  MURR’s unparalleled reputation for quality control and reliable irradiation services will complement ABK in the research and development of Eye90 microspheres™ for the treatment of liver tumors.